354 related articles for article (PubMed ID: 18425350)
1. Thermosensitization by parthenolide in human lung adenocarcinoma A549 cells and p53- and hsp72-independent apoptosis induction via the nuclear factor-kappaB signal pathway.
Hayashi S; Hatashita M; Hayashi A; Matsumoto H; Shioura H; Kitai R
Int J Mol Med; 2008 May; 21(5):585-92. PubMed ID: 18425350
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of NF-kappaB by combination therapy with parthenolide and hyperthermia and kinetics of apoptosis induction and cell cycle arrest in human lung adenocarcinoma cells.
Hayashi S; Sakurai H; Hayashi A; Tanaka Y; Hatashita M; Shioura H
Int J Mol Med; 2010 Jan; 25(1):81-7. PubMed ID: 19956905
[TBL] [Abstract][Full Text] [Related]
3. Thermosensitization and induction of apoptosis or cell-cycle arrest via the MAPK cascade by parthenolide, an NF-κB inhibitor, in human prostate cancer androgen-independent cell lines.
Hayashi S; Koshiba K; Hatashita M; Sato T; Jujo Y; Suzuki R; Tanaka Y; Shioura H
Int J Mol Med; 2011 Dec; 28(6):1033-42. PubMed ID: 21805026
[TBL] [Abstract][Full Text] [Related]
4. Sesquiterpene lactone parthenolide markedly enhances sensitivity of human A549 cells to low-dose oxaliplatin via inhibition of NF-kappaB activation and induction of apoptosis.
Fang LJ; Shao XT; Wang S; Lu GH; Xu T; Zhou JY
Planta Med; 2010 Feb; 76(3):258-64. PubMed ID: 19774508
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor-kappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo.
Zhang D; Qiu L; Jin X; Guo Z; Guo C
Mol Cancer Res; 2009 Jul; 7(7):1139-49. PubMed ID: 19584264
[TBL] [Abstract][Full Text] [Related]
6. Modification of thermosensitivity by amrubicin or amrubicinol in human lung adenocarcinoma A549 cells and the kinetics of apoptosis and necrosis induction.
Hayashi S; Hatashita M; Matsumoto H; Jin ZH; Shioura H; Kano E
Int J Mol Med; 2005 Sep; 16(3):381-7. PubMed ID: 16077943
[TBL] [Abstract][Full Text] [Related]
7. Parthenolide cooperates with NS398 to inhibit growth of human hepatocellular carcinoma cells through effects on apoptosis and G0-G1 cell cycle arrest.
Ralstin MC; Gage EA; Yip-Schneider MT; Klein PJ; Wiebke EA; Schmidt CM
Mol Cancer Res; 2006 Jun; 4(6):387-99. PubMed ID: 16778086
[TBL] [Abstract][Full Text] [Related]
8. P53-independent thermosensitization by mitomycin C in human non-small-cell lung cancer cells.
Jin ZH; Matsumoto H; Hayashi S; Hatashita M; Ohtsubo T; Shioura H; Kitai R; Kano E
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):852-60. PubMed ID: 15183489
[TBL] [Abstract][Full Text] [Related]
9. Parthenolide, a natural inhibitor of Nuclear Factor-kappaB, inhibits lung colonization of murine osteosarcoma cells.
Kishida Y; Yoshikawa H; Myoui A
Clin Cancer Res; 2007 Jan; 13(1):59-67. PubMed ID: 17200339
[TBL] [Abstract][Full Text] [Related]
10. Parthenolide sensitizes cells to X-ray-induced cell killing through inhibition of NF-kappaB and split-dose repair.
Mendonca MS; Chin-Sinex H; Gomez-Millan J; Datzman N; Hardacre M; Comerford K; Nakshatri H; Nye M; Benjamin L; Mehta S; Patino F; Sweeney C
Radiat Res; 2007 Dec; 168(6):689-97. PubMed ID: 18088190
[TBL] [Abstract][Full Text] [Related]
11. Vitamins K1 and K2 potentiate hyperthermia by down-regulating Hsp72 expression in vitro and in vivo.
Shimohara S; Murakami T; Morikawa M; Matsuo J; Nagayama S; Shuto T; Suico MA; Okiyoneda T; Yamatsu I; Mizushima T; Shimasaki T; Kai H
Int J Oncol; 2005 Dec; 27(6):1527-33. PubMed ID: 16273208
[TBL] [Abstract][Full Text] [Related]
12. Hsp72 controls bortezomib-induced HepG2 cell death via interaction with pro-apoptotic factors.
Calvaruso G; Giuliano M; Portanova P; Pellerito O; Vento R; Tesoriere G
Oncol Rep; 2007 Aug; 18(2):447-50. PubMed ID: 17611669
[TBL] [Abstract][Full Text] [Related]
13. Intracellular inhibitory effects of Velcade correlate with morphoproteomic expression of phosphorylated-nuclear factor-kappaB and p53 in breast cancer cell lines.
Lun M; Zhang PL; Siegelmann-Danieli N; Blasick TM; Brown RE
Ann Clin Lab Sci; 2005; 35(1):15-24. PubMed ID: 15830705
[TBL] [Abstract][Full Text] [Related]
14. Hyperthermia potentiates oncolytic herpes viral killing of pancreatic cancer through a heat shock protein pathway.
Eisenberg DP; Carpenter SG; Adusumilli PS; Chan MK; Hendershott KJ; Yu Z; Fong Y
Surgery; 2010 Aug; 148(2):325-34. PubMed ID: 20633729
[TBL] [Abstract][Full Text] [Related]
15. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line.
Yasuoka Y; Naomoto Y; Yamatsuji T; Takaoka M; Kimura M; Uetsuka H; Matsubara N; Fujiwara T; Gunduz M; Tanaka N; Haisa M
Exp Cell Res; 2001 Dec; 271(2):214-22. PubMed ID: 11716533
[TBL] [Abstract][Full Text] [Related]
16. All-trans-retinoic acid upregulates TNF receptors and potentiates TNF-induced activation of nuclear factors-kappaB, activated protein-1 and apoptosis in human lung cancer cells.
Manna SK; Aggarwal BB
Oncogene; 2000 Apr; 19(17):2110-9. PubMed ID: 10815802
[TBL] [Abstract][Full Text] [Related]
17. p53 status-dependent sensitization of human tumour cells to hyperthermia by plant flavonol.
Hamamoto T; Suzuki K; Yamauchi M; Kodama S; Sasaki H; Watanabe M
Int J Hyperthermia; 2008 Aug; 24(5):415-24. PubMed ID: 18608579
[TBL] [Abstract][Full Text] [Related]
18. [Cross-talk between nuclear factor-kappaB and P53 signal pathway in keratinocytes after ultraviolet B irradiation].
Wang P; Song XZ; Bi ZG; Xu AE; Cui YG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3088-91. PubMed ID: 18261359
[TBL] [Abstract][Full Text] [Related]
19. Antimyeloma effects of a sesquiterpene lactone parthenolide.
Suvannasankha A; Crean CD; Shanmugam R; Farag SS; Abonour R; Boswell HS; Nakshatri H
Clin Cancer Res; 2008 Mar; 14(6):1814-22. PubMed ID: 18347184
[TBL] [Abstract][Full Text] [Related]
20. The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro.
Steele AJ; Jones DT; Ganeshaguru K; Duke VM; Yogashangary BC; North JM; Lowdell MW; Kottaridis PD; Mehta AB; Prentice AG; Hoffbrand AV; Wickremasinghe RG
Leukemia; 2006 Jun; 20(6):1073-9. PubMed ID: 16628188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
